Research on 966 mother-child pairs from the Childhood Autism Risks from Genetics and the Environment (CHARGE) Study finds that prenatal SSRI exposure was nearly 3 times as likely in children with autism spectrum disorder. Exposure was more than 3 times as likely among boys with development delay, and nearly five times as likely when the exposure was in the third trimester. Results appeared yesterday in Pediatrics.
Harrington, R., Lee, L., Crum, R., Zimmerman, A., Hertz-Picciotto, I.; Prenatal SSRI Use and Offspring With Autism Spectrum Disorder or Developmental Delay. Pediatrics. Online April 14, 2014